A kind of medicinal composition for treating insomnia

A composition and drug technology, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of epileptic seizures, hallucinations, drug dependence, etc., and achieve the effect of good treatment of insomnia, reliable effect, and easy preparation

Active Publication Date: 2020-08-21
ZHEJIANG ASEN PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Hypnotics commonly used clinically at present include benzodiazepines, barbiturates and other non-barbiturates. The effect of treating insomnia is relatively obvious, but it has a greater impact on the liver and kidney, and users are prone to drug reactions. Dependence, usually increasing the dosage of medicine to maintain the effect, but also produce a lot of toxic side effects, so it is not suitable for long-term use of drugs
Some people who take a large amount of drugs for a long time, if they suddenly reduce the dose or stop taking them, they will also be accompanied by nausea or vomiting, coarse tremors in the hands, tongue and eyelids, leading to behavioral disturbances, hallucinations, and even seizures

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of medicinal composition for treating insomnia
  • A kind of medicinal composition for treating insomnia
  • A kind of medicinal composition for treating insomnia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Embodiment 1: The pharmaceutical composition for the treatment of insomnia

[0020] Part A as granules:

[0021] Codonopsis 140g, Stir-fried Atractylodes macrocephala 280g, Sun-roasted Astragalus membranaceus 140g, Sun-roasted licorice 70g, Poria cocos 280g, Polygala 280g, Stir-fried Suanzaoren 140g, Longan meat 280g, Angelica 280g, Muxiang 70g, Pitted jujube 70g;

[0022] The original medicinal material is about 2030g. After water extraction and concentration, about 500g of extract with a relative density of 1.10-1.15 is obtained. After adding an appropriate amount of dextrin for granulation, about 1000g of Guipi Granules is obtained.

[0023] Part B as a capsule:

[0024] 180g Bupleurum, 360g Uncaria, 270g Angelica, 180g Chuanxiong, 360g Poria, 360g Shouwuteng, 360g Fried Atractylodes Rhizome, 136g Licorice.

[0025] Preparation Process:

[0026] 1. Crush and sterilize: Take half of Bupleuri and half of Uncaria to crush, sieve, and sterilize for later use.

[0027...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition for treating insomnia, and belongs to the technical field of traditional Chinese medicines. The pharmaceutical composition for treating insomnia comprises two parts of medicines A and B, the part A comprises 1-10 parts by weight of a medicinal composition in a Guipi particle, the part B comprises 1-5 parts by weight of a medicinal composition in an Anle capsule; the medicinal composition in the Anle capsule is prepared from the following medicines: 180 g of radix bupleuri, 360 g of uncaria, 270 g of angelica sinensis, 180 g of ligusticum wallichii, 360 g of poria cocos, 360 g of vine of multiflower knotweed, 360 g of rhizoma atractylodis macrocephalae stir-fried with bran, and 136 g of liquorice. The medicine components are dialectically compatible, supplement one another on the actions, produce a synergistic effect, and play the roles in tonifying lung and spleen, soothing liver, regulating qi, promoting circulation of qi, eliminating depression, and tranquilizing mind, so that the purpose of treating both symptoms and root causes of insomnia is achieved. The pharmaceutical composition has remarkable effects on treating insomnia, is reliable in actions and mild in drug properties, and does not have toxic or side effects, the total effective rate is 91.67%, and the curative rate is up to 61.67%.

Description

technical field [0001] The invention relates to a medicinal composition for treating insomnia, which belongs to the technical field of traditional Chinese medicine. Background technique [0002] Insomnia, known as "can't lie down" or "can't sleep" in ancient literature, is a syndrome characterized by frequent difficulty in falling asleep. There are many causes of insomnia, such as thinking and fatigue, internal sadness and spleen, disharmony between yang and yin, disharmony between heart and kidney, deficiency of yin and hyperactivity of fire, disturbance of liver yang, deficiency of heart and gallbladder qi, accumulation of phlegm and dampness, and disharmony in the stomach, etc., all of which can affect the mind. leading to insomnia. Zhang Jingyue said: "Sleep is inherently yin, and the god is the master. If the god is peaceful, you can sleep, and if you are restless, you can't sleep. The reason for restlessness is that it is disturbed by evil energy, and the ear is not e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/77A61K36/74A61K9/16A61K9/48A61P25/20
CPCA61K9/1652A61K36/076A61K36/232A61K36/233A61K36/236A61K36/284A61K36/285A61K36/344A61K36/481A61K36/484A61K36/69A61K36/704A61K36/725A61K36/74A61K36/77A61K2236/331A61K2300/00
Inventor 邓金明
Owner ZHEJIANG ASEN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products